BIOA

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 001.45 M2.41 M2.05 M 5.92 M Gross profit 001.45 M2.41 M2.05 M 5.92 M Operating expenses 24.75 M25.36 M17.9 M27.18 M25.19 M 95.64 M Selling/general/admin expenses 4.73 M6.14 M6.79 M7.34 M6.68 M 26.95 M Research & development 20.02 M19.23 M11.11 M19.84 M18.51 M 68.69 M Operating income 24.75 M25.36 M16.45 M24.77 M23.14 M 89.72 M Non-Operating Income, Total 1.34 M3.88 M3.52 M3.21 M2.97 M 13.57 M Interest expense, net of interest capitalized 388 K319 K255 K201 K149 K 924 K Non-Operating Income, excl. Interest Expenses 955 K3.56 M3.26 M3.01 M2.82 M 12.65 M Unusual income/expense ————— — Pretax income 25.7 M71.11 M19.71 M27.78 M25.96 M 144.56 M Equity in earnings ————— — Taxes —29.81 M——— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 23.41 M21.13 M12.93 M21.56 M20.17 M 75.79 M Discontinued operations ————— — Net income 23.41 M21.13 M12.93 M21.56 M20.17 M 75.79 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 23.41 M21.13 M12.93 M21.56 M20.17 M 75.79 M Basic earnings per share (Basic EPS) -6.715.77-0.36-0.6-0.56 14.25 Diluted earnings per share (Diluted EPS) -6.715.77-0.36-0.6-0.56 14.25 Average basic shares outstanding 3.49 M10.73 M35.85 M35.85 M35.85 M 118.28 M Diluted shares outstanding 3.49 M10.73 M35.85 M35.85 M35.85 M 118.28 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 38 K47 K37 K58 K49 K 191 K